C2C Innovative Solutions (Won Maximus Medicare Advantage Appeals Contract May 2026)
node
When a smaller company beat out the dominant contractor for a Medicare job, it proved the giant isn't actually untouchable everywhere.
Who they are
C2C Innovative Solutions, which won the Maximus Medicare Advantage appeals contract in May 2026.
What they do
In the engine's read it's a deliberately pre-registered test the engine set for itself — and this outcome disproved part of its own thesis.
How it works
CMS announced in May 2026 (effective immediately) that C2C would take over reviewing Medicare Advantage appeals and reconsiderations, replacing Maximus, which had held the work; it's one of two pre-registered falsifications in Report #86 (the other being Maximus's child-support divestiture).
Why it matters
It shows the federal government keeps real alternatives in specific Medicare areas, so Maximus's dominance isn't absolute — it's concentrated at the 1-800-MEDICARE and Healthcare.gov contact-center keystone, not everywhere.
The engine's record — word for word
Report #86. Empirical sub-thesis falsification node. CMS announced May 2026 (effective immediately) that C2C Innovative Solutions won the contract for reviewing and processing appeals of Medicare Advantage adverse organization determinations and reconsiderations — REPLACING Maximus, which had previously held the work. This is one of two transparent BST III pre-registered falsifications in Report #86 (the other being Maximus's Q1 FY2026 Title IV-D child support divestiture). It demonstrates that the federal layer retains operational alternatives in specific Medicare sub-domains and that Maximus's CMS dominance is not absolute across every program category — only at the 1-800-MEDICARE + Healthcare.gov contact center keystone.
Follow the trail
Walk this on the live map →